UCB competitors

John Fraher is a Chief Executive Officer at Aptalis Pharma Inc, Chief Executive Officer at Eurand NV, and Board Member at Ellodi Pharmaceuticals and is based in United States. He has worked as Pres:Aptalis Pharma Technologies at Aptalis Pharma Inc, Production Manager at Fort Dodge Animal Health, and President at Aptalis Pharma Inc. John works or has worked as President:America at Eurand Pharmaceuticals Hldg. He attended University College Dublin between 1984 and 1989.

Matthew Roberts is a Chief Executive Officer at ASTELLAS PHARMA US, INC. and is based in Decatur, Georgia.

Country Manager enabling teams to deliver the present and charter the future aspirations, setting vision, strategising to capitalise on emerging opportunities in India and South Asian regions. P&L leader with multiple TA domain expertise, and across geographies in leading MNC,Indian companies with cultural diversity. Expertise in healthcare Sales& Marketing, Strategy, Business operations, new business venture management, strategic planning, managing acquisition, strategic alliance management, and International Business ( Includes Indian subcontinent of Srilanka, Bangladesh, Pakistan, Maldives etc), and exposure across AP markets. Expertise in leading profitable growth at South west Asia cluster country level. specialty,chronic and mass base business units across leading MNC & Indian companies.Setting up of Key Account Management and international business.

Craig Landau is a President/CEO at Purdue Biopharma LP and President/CEO at PURDUE PHARMA and is based in Stamford, Connecticut. He has worked as Major at United States Army, Associate Medical Director at Knoll Pharmaceutical Co, and Executive Medical Director at PURDUE PHARMA. Craig attended WINTHROP-UNIVERSITY HOSPITAL between 1991 and 1992, Icahn School of Medicine at Mount Sinai between 1987 and 1991, and Yale University-School of Medicine between 1992 and 1995.